Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
World Journal of Gastroenterology
|
February 3, 2022
Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison
Chun-Ting Chen, Ming-Ying Lu, Meng-Hsuan Hsieh, et al.
Journal of Gastroenterology and Hepatology
|
March 2, 2021
Comorbidities in patients with chronic hepatitis C and hepatitis B on hemodialysis
Po-Yao Hsu, Yu-Ju Wei, Po-Cheng Liang, et al.
Virology Journal
|
June 2, 2023
Impact of comorbidities on the serological response to COVID-19 vaccination in a Taiwanese cohort
Chung-Feng Huang, Tyng-Yuan Jang, Ping-Hsun Wu, et al.
Scientific Reports
|
April 15, 2021
Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
Tyng-Yuan Jang, Yu-Ju Wei, Ta-Wei Liu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
October 28, 2020
Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
Tyng-Yuan Jang, Yu-Ju Wei, Ming-Lun Yeh, et al.
Clinical and Molecular Hepatology
|
December 15, 2020
Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis
Po-Yao Hsu, Yu-Ju Wei, Jia-Jung Lee, et al.
Plos One
|
November 20, 2020
The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C
Jia-Jung Lee, Yu-Ju Wei, Ming-Yen Lin, et al.
Journal of Viral Hepatitis
|
February 3, 2021
Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like Group
Yu-Ju Wei, Po-Yao Hsu, Jia-Jung Lee, et al.
American Journal of Cancer Research
|
January 11, 2023
Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinoma
Po-Yao Hsu, Po-Cheng Liang, Wen-Tsan Chang, et al.
Cancer Medicine
|
November 17, 2021
Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels
Po-Yao Hsu, Tzu-Sheng Cheng, Shih-Chang Chuang, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
World Journal of Gastroenterology
|
February 3, 2022
Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison
Chun-Ting Chen, Ming-Ying Lu, Meng-Hsuan Hsieh, et al.
Journal of Gastroenterology and Hepatology
|
March 2, 2021
Comorbidities in patients with chronic hepatitis C and hepatitis B on hemodialysis
Po-Yao Hsu, Yu-Ju Wei, Po-Cheng Liang, et al.
Virology Journal
|
June 2, 2023
Impact of comorbidities on the serological response to COVID-19 vaccination in a Taiwanese cohort
Chung-Feng Huang, Tyng-Yuan Jang, Ping-Hsun Wu, et al.
Scientific Reports
|
April 15, 2021
Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
Tyng-Yuan Jang, Yu-Ju Wei, Ta-Wei Liu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
October 28, 2020
Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
Tyng-Yuan Jang, Yu-Ju Wei, Ming-Lun Yeh, et al.
Clinical and Molecular Hepatology
|
December 15, 2020
Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis
Po-Yao Hsu, Yu-Ju Wei, Jia-Jung Lee, et al.
Plos One
|
November 20, 2020
The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C
Jia-Jung Lee, Yu-Ju Wei, Ming-Yen Lin, et al.
Journal of Viral Hepatitis
|
February 3, 2021
Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like Group
Yu-Ju Wei, Po-Yao Hsu, Jia-Jung Lee, et al.
American Journal of Cancer Research
|
January 11, 2023
Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinoma
Po-Yao Hsu, Po-Cheng Liang, Wen-Tsan Chang, et al.
Cancer Medicine
|
November 17, 2021
Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels
Po-Yao Hsu, Tzu-Sheng Cheng, Shih-Chang Chuang, et al.
Page
of 7